Rapid Micro Biosystems Inc

Rapid Micro Biosystems, Inc. is a life sciences technology company that provides products for detecting microbial contamination in the manufacture of pharmaceuticals, biologics, medical devices, and personal care products. It operates in the United States, Switzerland, Germany, Japan, and internationally. The company offers the Growth Direct platform, which includes the Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services. This platform automates and modernizes manual microbial quality control (MQC) testing workflows for therapeutic modalities such as biologics, cell and gene therapies, vaccines, and sterile injectables. The company also provides onsite technical training services, and its solutions are used in environmental monitoring, water, bioburden, and sterility release testing applications. Additionally, it offers RMBNucleus Mold Alarm software and Growth Direct LIMS connection software. Rapid Micro Biosystems, Inc. was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. The company was incorporated in 2006 and is headquartered in Lexington, Massachusetts.

RPID▲2

Rapid Micro Biosystems Q2 revenue rises 11%, raises validation target

Rapid Micro Biosystems reported second-quarter revenue of $8.1 million, up 11% from a year earlier, driven by record consumable sales and higher service activity. Gross margin improved to 15% from 4%, while service margin reached a record 49%. The company reaffirmed its full-year 2026 revenue outlook of $37 million to $41 million and raised its annual system-validation target to at least 27. Management expects fourth-quarter gross margin in the mid- to high-20% range and announced an efficiency program that should reduce cash usage by about $1 million for the rest of 2026 and $3 million annually from 2027, targeting positive cash flow by the end of 2028.

RPID ▲

MarketBeat·42dRead more →